← The Wire
OKYONasdaq
OKYO Pharma Ltd
Biological Products, (No Diagnostic Substances) · CIK 1849296
OKYO Pharma develops next-generation therapeutics for inflammatory eye diseases and ocular pain
$80M
Market cap
$1.52
Last close
-1.9%
1D
-3.2%
5D
34K
Volume
Price · last 39 sessions-9.5%
May 4L $1.49 · H $1.72Jun 29
153
Total filings
May 19, 2026
Last filing
—
Fiscal year end
424B5424B5Feb 17, 2026424B5424B5Feb 12, 2026424B5424B5Feb 11, 2026424B5424B5Jun 11, 2025424B5424B5Dec 20, 2023424B5424B5Dec 18, 2023424B5424B5Oct 31, 2023424B5424B5Sep 15, 2023424B5424B5Sep 13, 2023424B5424B5Jul 28, 2023
Similar companies
Comparable business profile · signals at a glance